BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32598779)

  • 1. [Idiopathic multicentric Castleman's disease].
    Vasilyev VI; Palshina SG; Pavlovskaya AI; Kokosadze NV; Chaltsev BD; Shornikova LA
    Ter Arkh; 2020 Jun; 92(5):78-84. PubMed ID: 32598779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
    Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
    Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic multicentric Castleman's disease: a systematic literature review.
    Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
    Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
    Sun C; Xu G; Lin J
    Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
    Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
    Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
    Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
    AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease.
    Otani K; Inoue D; Fujikura K; Komori T; Abe-Suzuki S; Tajiri T; Itoh T; Zen Y
    Oncotarget; 2018 Jan; 9(6):6691-6706. PubMed ID: 29467920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
    Lajoie G; Kumar S; Min KW; Silva FG
    Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
    Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
    BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of IgG4-related lung disease associated with multicentric Castleman's disease and lung cancer.
    Ikari J; Kojima M; Tomita K; Nakamura T; Toyoda F; Otsuki Y; Shimizu S; Kobayashi H; Nakamura H
    Intern Med; 2010; 49(13):1287-91. PubMed ID: 20606361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological significance of plasma cell infiltration in diagnosing lymph node diseases].
    Hu H; Jiang YJ; Xu L; Yin LJ; Liu XF; Yin SY; Xu JJ; He MX
    Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):702-709. PubMed ID: 37408401
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
    Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
    Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
    Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
    Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Castleman's disease.
    Shahidi H; Myers JL; Kvale PA
    Mayo Clin Proc; 1995 Oct; 70(10):969-77. PubMed ID: 7564550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric Castleman's disease: Report of three cases.
    Guazzaroni M; Bocchinfuso F; Vasili E; Lacchè A; Ranalli T; Garipoli A; Di Tosto F; Floris R
    Radiol Case Rep; 2019 Mar; 14(3):328-332. PubMed ID: 30581518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease.
    Kawanishi M; Kamei F; Sonoda H; Oba M; Fukunaga S; Egawa M; Koyama T; Sato Y; Tanabe K; Ito T
    CEN Case Rep; 2023 May; 12(2):242-248. PubMed ID: 36414812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Nishimoto N; Sasai M; Shima Y; Nakagawa M; Matsumoto T; Shirai T; Kishimoto T; Yoshizaki K
    Blood; 2000 Jan; 95(1):56-61. PubMed ID: 10607684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transitional type of Castleman's disease manifested as the POEMS syndrome].
    Tomić I; Plavec G; Tasić O; Ristanović A; Cvijanović V
    Vojnosanit Pregl; 2004; 61(4):439-44. PubMed ID: 15552541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castleman's disease associated with pemphigus vulgaris.
    Gili A; Ngan BY; Lester R
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):955-9. PubMed ID: 1761779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.